We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+16.53%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$6.64M
Cap. Flow
-$8.72M
Cap. Flow %
-4.75%
Top 10 Hldgs %
35.79%
Holding
86
New
25
Increased
22
Reduced
18
Closed
18

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$3.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.21M
3
DHR icon
Danaher
DHR
+$2.92M
4
XLRN
Acceleron Pharma
XLRN
+$2.43M
5
ESPR
Esperion Therapeutics
ESPR
+$2.41M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$6.61M
2
AGN
Allergan plc
AGN
+$6.08M
3
SPNC
Spectranetics Corp
SPNC
+$4.22M
4
SNY icon
Sanofi
SNY
+$3.59M
5
CELG
Celgene Corp
CELG
+$3.06M

Sector Composition

Rank Sector Weight
1 Healthcare 76.63%
2 Financials 2.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
26
Danaher
DHR
$147B
$3M 1.64%
+39,480
New +$2.92M
SGMO
27
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3M 1.63%
200,000
-15,000
-7% -$166K
XENT
28
DELISTED
Intersect ENT, Inc
XENT
$2.8M 1.53%
90,000
+20,000
+29% +$592K
MRUS
29
DELISTED
Merus
MRUS
$2.78M 1.52%
140,000
-35,000
-20% -$559K
RARE icon
30
Ultragenyx Pharmaceutical
RARE
$2.64B
$2.66M 1.45%
50,000
-25,000
-33% -$1.48M
XLRN
31
DELISTED
Acceleron Pharma
XLRN
$2.61M 1.42%
+70,000
New +$2.43M
KYNB
32
Kyntra Bio
KYNB
$28.2M
$2.15M 1.17%
+1,600
New +$1.69M
PFE icon
33
Pfizer
PFE
$154B
$2.14M 1.17%
+63,240
New +$2.03M
CCXI
34
DELISTED
ChemoCentryx, Inc.
CCXI
$2.04M 1.11%
275,000
+25,000
+10% +$208K
CBAY
35
DELISTED
Cymabay Therapeutics
CBAY
$2.02M 1.1%
250,000
+145,000
+138% +$980K
CAH icon
36
Cardinal Health
CAH
$55.5B
$2.01M 1.09%
+30,000
New +$2.12M
ANAB icon
37
AnaptysBio
ANAB
$1.64B
$1.75M 0.95%
50,000
-20,000
-29% -$539K
ADMA icon
38
ADMA Biologics
ADMA
$2.18B
$1.74M 0.95%
565,000
+415,000
+277% +$1.38M
AVXS
39
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.69M 0.92%
17,500
-12,500
-42% -$1.13M
ESRX
40
DELISTED
Express Scripts Holding Company
ESRX
$1.58M 0.86%
+25,000
New +$1.55M
OMED
41
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.58M 0.86%
350,000
-50,000
-13% -$203K
INSM icon
42
Insmed
INSM
$29.4B
$1.56M 0.85%
+50,000
New +$952K
RXDX
43
DELISTED
Ignyta, Inc.
RXDX
$1.54M 0.84%
125,000
+75,000
+150% +$773K
ARNA
44
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.53M 0.83%
+60,000
New +$1.38M
CORI
45
DELISTED
Corium International, Inc.
CORI
$1.39M 0.75%
125,000
+25,000
+25% +$221K
KURA icon
46
Kura Oncology
KURA
$874M
$1.35M 0.73%
+90,000
New +$845K
CTMX icon
47
CytomX Therapeutics
CTMX
$750M
$1.27M 0.69%
70,000
+10,000
+17% +$156K
DPLO
48
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.24M 0.68%
60,000
-15,000
-20% -$254K
CTLT
49
DELISTED
CATALENT, INC.
CTLT
$1.2M 0.65%
+30,000
New +$1.11M
WVE icon
50
Wave Life Sciences
WVE
$1.2B
$1.2M 0.65%
55,000
– –
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2017 Portfolio in Review

As of Q3 2017, Iguana Healthcare Management held 86 positions worth $184M, up 3.8% from $177M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Iguana Healthcare Management withdrew a net $8.72M in Q3 2017, closing 18 positions and reducing 18 holdings. Its most notable exit was Shire pic, an estimated $6.61M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 70% a quarter earlier, followed by Financials.

Against the trend, Iguana Healthcare Management opened a new position in Bristol-Myers Squibb worth $3.51M.

  • Iguana Healthcare Management's largest Q3 2017 buy was Bristol-Myers Squibb: 55,000 shares worth $3.51M.
  • Iguana Healthcare Management added most to Biogen in Q3 2017, an estimated $3.7M increase.
  • Iguana Healthcare Management's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $3.06M.
  • Iguana Healthcare Management fully exited Shire pic in Q3 2017, selling an estimated $6.61M.
  • Iguana Healthcare Management's ten largest holdings make up 36% of its $184M portfolio in Q3 2017.
  • Iguana Healthcare Management opened 25 new positions and closed 18 in Q3 2017.
  • Iguana Healthcare Management's portfolio value rose 3.8% quarter-over-quarter to $184M.

Based on Iguana Healthcare Management's 13F filing for Q3 2017, filed 14 Nov 2017.